# Novartis Pharma Stein AG – FDA Inspection, May 19, 2026

Source: https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/a633da96-4e8c-467f-bbb0-0fc11887d34d
Source feed: FDA_Inspections

> FDA inspection 1319902 of Novartis Pharma Stein AG, May 19, 2026. 2 citations under 21 CFR part 211. Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1319902
- Company Name: Novartis Pharma Stein AG
- Inspection Date: 2026-05-19
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Office of Inspections and Investigations
- Citation Count: 2

## Related Documents

- FDA Inspection 1230809 - 2023-11-20
- [FDA Inspection 1192104 - 2022-12-06](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/5994d6f5-291c-4a32-87bf-4376f992a6bb)
- [FDA Inspection 1073408 - 2018-12-04](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/3f2284e9-7b71-4b40-a3f0-ac4686b89e80)
- [FDA Inspection 1071638 - 2018-09-21](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/f5f3d4b8-2f6a-4b3c-96c5-b17bb730a41f)
- [FDA Inspection 1025563 - 2017-08-24](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/f7f14324-13d3-44e9-802f-d55ecc1beaae)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/travis-s-bradley/4d7756cb-65fd-4bd6-be24-25710668e6d8)

Company: https://www.keypedia.com/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8